Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Endocyte ECYT

Healthcare Biotechnology
"Endocyte Inc is a biopharmaceutical company. It is engaged in developing targeted therapies for the treatment of cancer and inflammatory diseases."

Recent & Breaking News (NDAQ:ECYT)

Endocyte Announces Presentations at the European Society for Medical Oncology (ESMO)

GlobeNewswire September 29, 2016

Endocyte to Present at the Ladenburg Thalmann 2016 Healthcare Conference

GlobeNewswire September 20, 2016

INVESTIndiana announces executive presentation schedule

GlobeNewswire September 6, 2016

Endocyte Announces Presentations at the 252nd American Chemical Society National Meeting & Exposition

GlobeNewswire August 15, 2016

Endocyte to Present at the 2016 Wedbush PacGrow Healthcare Conference

GlobeNewswire August 9, 2016

Endocyte Reports Second Quarter 2016 Financial Results

GlobeNewswire August 4, 2016

Endocyte Announces Second Quarter 2016 Earnings Conference Call

GlobeNewswire July 28, 2016

Endocyte Appoints Mike Sherman as President and Chief Executive Officer

GlobeNewswire June 20, 2016

Mid-Afternoon Market Update: Crude Oil Up Over 3%; Lumber Liquidators Shares Spike Higher

Benzinga.com  June 17, 2016

Endocyte to Announce Updated Data on EC1456 and EC1169 at the 2016 American Society of Clinical Oncology (ASCO) Annual Meeting

GlobeNewswire May 26, 2016

Endocyte Reports First Quarter 2016 Financial Results

GlobeNewswire May 4, 2016

TubeMogul Certifies Over 100 Executives and Media Traders in 2016

GlobeNewswire May 4, 2016

Endocyte Announces First Quarter 2016 Earnings Conference Call

GlobeNewswire April 27, 2016

Endocyte Announces Promising Preclinical Data for Application of SMDC Technology in CAR T Cell Therapy in Late-Breaking Abstract at American Association for Cancer Research (AACR) Annual Meeting 2016

GlobeNewswire April 19, 2016

Endocyte Announces Presentations at American Association for Cancer Research (AACR) Annual Meeting 2016

GlobeNewswire April 11, 2016

Endocyte Reports Fourth Quarter and Year End 2015 Financial Results and Provides Clinical and Pipeline Update

GlobeNewswire March 2, 2016

Endocyte Announces Fourth Quarter and Full Year 2015 Earnings Conference Call

GlobeNewswire February 24, 2016

Endocyte to Present at Upcoming Conferences

GlobeNewswire February 16, 2016

Endocyte Reports Third Quarter 2015 Financial Results and Provides Update on Clinical Progress

GlobeNewswire November 3, 2015

Endocyte Announces Third Quarter 2015 Earnings Conference Call

GlobeNewswire October 27, 2015